PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)
Close on Nov 17, 2026Market cap $12.07MP/E –Yield –
PAVmed ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
PAVmed's ebitda for the twelve months ending Jun 30, 2026 was -$26.63M. For fiscal 2025 it was -$21.70M. The highest annual figure on record is -$21.70M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.70M | – |
| FY2024 | Dec 31, 2024 | -$43.29M | – |
| FY2023 | Dec 31, 2023 | -$65.86M | – |
| FY2022 | Dec 31, 2022 | -$88.63M | – |
| FY2021 | Dec 31, 2021 | -$54.17M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.00M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.02M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.79M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.82M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.69M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.40M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.12M | – |
| Q3 FY2024 | Sep 30, 2024 | -$11.34M | – |
| Q2 FY2024 | Jun 30, 2024 | -$13.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$15.66M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.80M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.74M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.67M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.88M | – |
| Q3 FY2022 | Sep 30, 2022 | -$22.67M | – |
| Q2 FY2022 | Jun 30, 2022 | -$22.67M | – |
| Q1 FY2022 | Mar 31, 2022 | -$19.42M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.51M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.64M | – |
See a number that looks wrong?